Mitochondrial microRNA (MitomiRs) in cancer and complex mitochondrial diseases: current status and future perspectives
- PMID: 33084945
- PMCID: PMC11072739
- DOI: 10.1007/s00018-020-03670-0
Mitochondrial microRNA (MitomiRs) in cancer and complex mitochondrial diseases: current status and future perspectives
Abstract
Mitochondria are not only important for cellular bioenergetics but also lie at the heart of critical metabolic pathways. They can rapidly adjust themselves in response to changing conditions and the metabolic needs of the cell. Mitochondrial involvement as well as its dysfunction has been found to be associated with variety of pathological processes and diseases. mitomiRs are class of miRNA(s) that regulate mitochondrial gene expression and function. This review sheds light on the role of mitomiRs in regulating different biological processes-mitochondrial dynamics, oxidative stress, cell metabolism, chemoresistance, apoptosis,and their relevance in metabolic diseases, neurodegenerative disorders, and cancer. Insilico analysis of predicted targets of mitomiRs targeting energy metabolism identified several significantly altered pathways (needs in vivo validations) that may provide a new therapeutic approach for the treatment of human diseases. Last part of the review discusses about the clinical aspects of miRNA(s) and mitomiRs in Medicine.
Keywords: Cancer; Cardiovascular disease; Clinical medicine; Diabetes; Metabolic disorders; Neurodegenerative disorders; microRNA; mitomiR.
Conflict of interest statement
Authors declare no conflict of interest.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
